NDC 51407-192
Ezetimibe and Simvastatin 10 mg / 40 mg tablet
On the label: Golden State Medical Supply, Inc.. It's repackaged: Golden State Medical Supply, Inc. rebottles it from Dr. Reddy's Laboratories Inc.'s NDC 43598-743.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Dr. Reddy's Laboratories Inc. DBA Dr. Reddy's Laboratories Louisiana, LLC | Location not on file | Makes it and tests it | Not inspected on record |
Repackaging site
- Golden State Medical Supply Inc., Camarillo, CA, United States · repackages it and relabels it
Recalls
- Oct 14, 2021 · Class II · Golden State Medical Supply Inc.
Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle
Lots: a) Lot: GS038610, Exp: 01/2023; b) GS038891, Exp: 1/2023 - Oct 14, 2021 · Class II · Golden State Medical Supply Inc.
Failed Excipient Specification; product manufactured using an excipient found to be OOS for conductivity
Lots: GS040048, Exp: 1/2023 - Oct 5, 2021 · Class II · Dr. Reddy's Laboratories, Inc.
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
Lots: a) L100256, exp 01/2023; b) L100257, exp 01/2023 - Oct 5, 2021 · Class II · Dr. Reddy's Laboratories, Inc.
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
Lots: a) L100298 and L100304, exp 01/2023 b) L100235, exp 01/2023 - Oct 5, 2021 · Class II · Dr. Reddy's Laboratories, Inc.
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
Lots: a) L100160, exp 01/2023 b) L100249, exp 01/2023 c) L100250, exp 01/2023 - Oct 5, 2021 · Class II · Dr. Reddy's Laboratories, Inc.
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
Lots: a) L100158, exp 12/2022 b) L100159, exp 12/2022 - Oct 5, 2021 · Class II · Dr. Reddy's Laboratories, Inc.
Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle
Lots: L100208, exp 01/2023
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Ezetimibe and Simvastatin: every company that makes it
- Form
- tablet, oral
- Strength
- 10 mg / 40 mg
- Approval
- ANDA ANDA200909
- On the market since
- Apr 26, 2017
- Package NDCs
51407-192-0551407-192-1051407-192-3051407-192-90- Official label
- DailyMed (National Library of Medicine), updated Nov 24, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?